| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |